(Reuters) – New York’s Attorney General said Monday that Teva Pharmaceutical Industries Ltd. lied to avoid responsibility for helping incite the state’s opioid crisis.
In a court report, Attorney General Letitia James said new evidence showed that a senior Teva chief of staff in an affidavit had made “proven false” statements that the parent did not market or sell opioids in the United States, or controlled Teva Pharmaceuticals’ US finances. or activities.
“This new evidence shows an even greater disregard for the pain and destruction that this company was committing,” and may constitute a “fraud in court,” James said.
The Attorney General also said that Teva̵7;s use of offshore accounts to protect potentially large sums of money from its US operations created “real concern” that the company might not pay damages following a December 30 Suffolk County jury ruling that the U.S. unit violated state laws on general inconvenience. .
In a statement, Teva said: “Teva denies having misled the court, and after the court is fully informed, we expect the judge to rule in our favor.”
The company said in May that it may have to pay $ 2.6 billion to solve US opioid trials across the country.
James’ lawsuit is among more than 3,300 filed by state, local and Native American tribal governments accusing drugmakers of toning down opioid addiction and distributors and pharmacies ignoring red flags about opioid abuse.
Teva was accused by Ms. James, Nassau County and Suffolk County for using misleading marketing of opioids, among other things by forcing them to off-label use.
The case focused on Teva’s generic drugs and Actiq and Fentora cancer treatments. Teva’s parent company was dismissed as respondent in December 2019.
A tort lawsuit has not yet been held.